At the White House, the Health and Human Services secretary left the misleading impression that the FDA’s decision to revoke its emergency use authorization of hydroxychloroquine and chloroquine for COVID-19 “removes a potential barrier” and makes it easier to access the drugs. The FDA’s action does the opposite.
Stories by Jessica McDonald
SciCheck Editor
Ahead of Trump Rally, Republicans Spin COVID-19 Metrics
Unpacking WHO’s Asymptomatic COVID-19 Transmission Comments
At a June 8 press conference, a World Health Organization scientist confusingly suggested that asymptomatic transmission of the coronavirus is “very rare” — a statement that many scientists found problematic, and which some politicians and those on social media seized upon as evidence that certain public health measures were not necessary.
Does Vitamin D Protect Against COVID-19?
Trump Misleads on Hydroxychloroquine, Again
Trump Baselessly Claims Coronavirus Will ‘Go Away’ Without Vaccine
How Many COVID-19 Tests Are ‘Needed’ to Reopen?
Trump Falsely Claims COVID-19 Death Projection Assumes ‘No Mitigation’
Dismissing concerns that states are reopening too soon, President Donald Trump incorrectly said that a newly revised model projecting 134,000 COVID-19 deaths by August “assumes no mitigation.” In fact, the model assumes states will keep their existing social distancing measures in place, unless suspensions have already been announced.